| Crystal Structure of Thrombin-activatable Fibrinolysis Inhibitor in Complex with two Inhibitory Nan… | |
Heteromer
| 23-423 | 99.0 | 3×NAG; 1×NAG; 1×ZN; |
|
| Crystal Structure of Thrombin-activatable Fibrinolysis Inhibitor in Complex with an Inhibitory Nano… | |
Heteromer
| 23-423 | 99.0 | 1×NAG; 3×NAG; 1×ZN; 1×ACT; |
|
| Crystal Structure of Thrombin-activatable Fibrinolysis Inhibitor in Complex with an Inhibitory Nano… | |
Heteromer
| 24-421 | 98.92 | 1×NAG; 3×NAG; 1×ZN; 1×FLC; |
|
| Structure of human activated thrombin-activatable fibrinolysis inhibitor, TAFIa, in complex with ti… | |
Heteromer
Q5EPH2; | 115-423 | 99.68 | 1×ZN; 1×GLY; 4×GOL; 3×CL; 1×CA; 2×K; |
|
| Inhibitor Complex with Thrombin Activatable Fibrinolysis inhibitor (TAFIa) | | monomer | 24-423 | 99.0 | 1×U9B; 1×ZN; |
|
| Crystal structure of a T325I/T329I/H333Y/H335Q mutant of Thrombin-Activatable Fibrinolysis Inhibito… | | monomer | 24-423 | 99.0 | 4×NAG; 1×ZN; 1×ARG; |
|
| Inhibitor Complex with Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) | | monomer | 24-423 | 98.74 | 1×U9K; 1×ZN; 1×NA; 1×CL; 1×EDO; 2×NAG; |
|
| Crystal structure of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) | | monomer | 24-423 | 99.5 | 4×NAG; 1×ZN; |
|
| Crystal structure of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) in complex with 2-guanidino… | | monomer | 24-423 | 99.5 | 4×NAG; 1×ZN; 1×GEM; |
|
| pro-carboxypeptidase U In Complex With 5-(3-aminopropyl)-1-propyl-6,7-dihydro-4H-benzimidazole-5-ca… | | monomer | 25-423 | 99.25 | 1×2B8; 1×ZN; 1×DMS; 1×NAG; |
|